Article

Victoza® LEAD Clinical Trial Program

Victoza® studies included nearly 4000 patients in the Liraglutide Effect and Action in Diabetes (LEAD) trials. Click here for more information.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Vaccine for the virus. Medical ampoules on a chessboard, defeat the king. Concept cure for coronavirus.
September 16th 2025

Op-Ed: Vaccine Policy Changes Are Undoing Pharmacy Access

Spreeha Choudhury, PharmD, JD Richard Hughes IV, JD, MPH
Pharmacy Focus Oncology Edition Podcast
September 16th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Man in red shirt holding stomach - Image credit: Mladen | stock.adobe.com
September 16th 2025

Study Finds Overweight Status May Aid Older Adults in Surgery Recovery

Kennedy Ferruggia, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 16th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 16th 2025

From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research

Abdulwhab Shremo Msdi, PharmD, BCIDP
law concept Judge law medical Pharmacy compliance Health care business rules - Image credit: onephoto | stock.adobe.com
September 16th 2025

Pharmacy Policy Updates for September 2025

Aislinn Antrim, Managing Editor
© 2025 MJH Life Sciences

All rights reserved.